Logistic Properties of the Americas Fourth Quarter 2025 Investor Presentation Disclaimer This presentation (the "Presentation") is provided for informational purposes only and has been prepared to provide interested parties with certain information about Logistic Properties of the Americas and its subsidiaries (collectively, "LPA") and for no other purpose. This Presentation is not a prospectus, product disclosure statement or any other offering or disclosure document under any other law. The information co ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 F O R M 6-K Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2026 TAT TECHNOLOGIES LTD. (Name of Registrant) 9335, Harris corners, Charlotte, N.C (Address of Principal Executive Office) Form 20-F ☒ Form 40-F ☐ Indicate by check mark if th ...

Full Year and Q4 2025 Earnings Presentation 19 MARCH 2026 z z Disclaimer This presentation ("Presentation") does not contain or constitute an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase any security of Alvotech (the "Company") to any person in the United States or in any jurisdiction to whom or in which such offer or solicitation is unlawful. Any trademarks, servicemarks, trade names and copyrights of the Company and other companies contained in this Presentation are th ...

Financial Data and Key Metrics Changes - The company reported strong pricing increases for both DRAM and NAND, with NAND prices increasing more than DRAM prices in the second quarter of 2026 [27] - The company expects modest volume growth for both DRAM and NAND in the third quarter, driven by supply constraints [28] Business Line Data and Key Metrics Changes - NAND demand is robust, particularly driven by data center growth and AI server requirements, with the company unable to meet the current demand levels [10][11] - DRAM supply impacts from new projects are expected to materialize towards fiscal year 2028, indicating continued tight supply conditions beyond 2026 [18][19] Market Data and Key Metrics Changes - The demand for NAND is significantly undersupplied, with growth driven by KV cache applications and shortages in HDDs [47] - The company anticipates that the demand forecast from customers for 2026 and 2027 continues to escalate, despite efforts to increase supply [19] Company Strategy and Development Direction - The company is expanding its NAND capacity by adding clean room space at existing sites, reflecting confidence in market demand [9][10] - The focus remains on disciplined capital expenditures while addressing the growing demand in the data center SSD space [12] Management's Comments on Operating Environment and Future Outlook - Management expressed that the supply constraints are expected to persist through 2026 and into 2027, with significant improvements in cleanroom space availability only anticipated by 2028 [67][70] - The company is optimistic about the long-term demand for DRAM and NAND, driven by AI and other emerging technologies, but acknowledges the challenges in meeting this demand [63][70] Other Important Information - The company has increased its capital expenditure outlook for FY 2026 to over $25 billion, primarily driven by DRAM and HBM investments [50] - Startup costs related to new fabs are expected to impact margins, but the company is managing these costs effectively [79] Q&A Session Summary Question: Can you discuss the decision to add greenfield capacity for NAND? - Management indicated that the decision was based on confidence in market demand and the need for additional clean room space for technology transitions [9][10] Question: How are you modeling the impact of new DRAM supply on pricing? - Management stated that new supply impacts will be felt in fiscal year 2028, and they expect tight supply conditions to continue beyond 2026 [18][19] Question: What is the outlook for NAND demand from KV cache applications? - Management confirmed that KV cache is a significant driver of demand, contributing to the overall growth in the data center SSD market [46] Question: How do you view the balance between HBM and non-HBM allocations? - Management emphasized that allocations are strategic and aimed at meeting customer needs, with both HBM and non-HBM margins being robust [40] Question: What is the expected CapEx mix for DRAM and NAND? - Management indicated that CapEx will be dominated by DRAM and HBM, with NAND expected to increase but remain a smaller portion of the overall spend [52] Question: How do you see the long-term bit growth for DRAM and NAND? - Management did not provide new long-term bit growth numbers but acknowledged that current forecasts are robust due to strong demand [63] Question: When do you expect to have enough cleanroom capacity to meet demand? - Management stated that significant improvements in cleanroom capacity are not expected until 2028, with ongoing evaluation of demand drivers [67][70]

Summary of Companhia Paranaense de Energia (Copel) Conference Call Company Overview - **Company**: Companhia Paranaense de Energia (Copel) - **Ticker**: NYSE: ELP - **Date of Call**: March 18, 2026 Key Points Industry Context - The conference focused on the results of the 2026 reserve capacity auction, emphasizing the importance of hydroelectric power in Brazil's energy sector, which is characterized by low costs and renewable energy sources [3][4]. Auction Results and Capacity Expansion - Copel's auction results indicate a significant increase in installed capacity: - Foz do Areia's capacity will increase from 1.7 gigawatts to 2.5 gigawatts, making it the eighth largest hydroelectric power plant in Brazil [4]. - Segredo's capacity will increase from 1.3 gigawatts to 2.5 gigawatts, positioning it as the ninth largest [5]. - The auction results are expected to enhance Copel's relevance in the national energy system and support its Strategy 2035 [4]. Financial Metrics and Investments - The estimated investment for the projects is as follows: - Foz do Areia: BRL 1.3 billion - Segredo: BRL 3.6 billion - Total for both assets: BRL 4.9 billion [6]. - The gross contracted price for the auction is BRL 1,395, with TUST (Transmission Use of System) costs ranging from BRL 575-610 for Foz do Areia and BRL 673-719 for Segredo [6]. Capital Allocation Strategy - Copel aims for a minimum payout of 75% of its dividend policy, indicating a commitment to returning value to shareholders despite the significant capital expenditures [9]. - The company plans to allocate approximately 15% of its capital expenditures (CapEx) in 2026, with a higher concentration of 40% in 2027 and 2028 for Foz do Areia [8][13]. Operational Efficiency and Future Outlook - The management emphasized the importance of operational efficiency, optimum leverage, and consistent returns as key pillars for value generation [7]. - The company is optimistic about the potential for early project completion, particularly for Foz do Areia, which may be operational by 2029 instead of the planned 2030 [14]. Debt and Funding Structure - The funding structure for the projects is expected to be 70% debt and 30% equity, leveraging Copel's strong market position as a Triple-A rated company [16]. Conclusion - The conference concluded with a positive outlook on Copel's future, highlighting the sustainable value generation from the recent auction and the strategic capital allocation moving forward [17]. This summary encapsulates the critical insights from the conference call, focusing on Copel's strategic initiatives, financial metrics, and industry positioning.

Financial Data and Key Metrics Changes - Revenue for Q4 2025 was $10,000, down from $24,000 in Q4 2024, reflecting modest revenue fluctuations in the early commercial stage [20] - Total revenue for 2025 was $81,000, slightly up from $77,000 in 2024, indicating a gradual revenue expansion [21] - Operating expenses for Q4 2025 were $9 million, down from $9.4 million in the prior year, showcasing disciplined expense management [20] - Net loss for Q4 2025 was $7.9 million compared to a net loss of $8.6 million in Q4 2024, demonstrating improved financial control [21] Business Line Data and Key Metrics Changes - Research and development expenses for 2025 were $13.2 million, down from $14.7 million in 2024, driven by lower clinical study costs following the completion of the PRIME study [21] - Selling, general, and administrative expenses were $23.3 million in 2025 compared to $21.9 million in 2024, reflecting targeted commercial readiness investments [21] Market Data and Key Metrics Changes - The company engaged with 13 states for partner programs, exceeding its initial goal of six states [9] - The strategy aims to expand to 15-17 states by year-end 2026, representing 58%-60% of U.S. births [9] Company Strategy and Development Direction - The company aims to build evidence, access, and commercial infrastructure to drive preTRM adoption at scale, with a focus on Medicaid and high preterm birth burden states [5][8] - Plans for 2026 include expanding partner programs and generating real-world evidence to support clinical adoption and reimbursement expansion [9][10] - The company is pursuing CE marking approval for the PreTRM Global Test in Europe, with submissions expected in the coming months [10] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the momentum gained from the PRIME publication and the engagement with payers and state legislators [35] - The company anticipates gradual adoption of its technology, supported by compelling clinical evidence and increasing payer engagement [45] Other Important Information - The company ended 2025 with $95.8 million in cash equivalents, providing a runway through 2028 for significant adoption and commercial milestones [22] - A new Head of Sales and Strategic Accounts was introduced, expected to enhance commercial execution and market access [15] Q&A Session Summary Question: Can you expand on converting payer discussions and partner programs using outcomes and economic data? - The company highlighted the importance of clinical outcomes and economic benefits for payers, particularly regarding NICU admissions and cost drivers [29][30] Question: What feedback was received at the SMFM conference regarding PRIME? - Engagement with providers and leadership at SMFM was positive, focusing on next steps to improve access to the test [33][35] Question: How will the company balance investments in U.S. states versus the EU launch? - The company plans to reallocate spending from clinical and R&D activities towards commercial activities, including EU opportunities [38] Question: Can you elaborate on the profile of new partners? - The company is negotiating with various partners, including large health systems and provider payers, to implement the PreTRM test into clinical workflows [40][42]

Financial Data and Key Metrics Changes - Total Payment Volume (TPV) reached $41 billion, up 60% year-over-year, with a significant acceleration as the year progressed [4] - Revenue surpassed $1 billion for the first time, with adjusted free cash flow of $191 million, up 110% year-over-year [7][19] - Net income reached $197 million, up 63% year-over-year, and adjusted EBITDA increased by 38% year-over-year [7][21] Business Line Data and Key Metrics Changes - TPV retention reached 158% and net revenue retention was 145%, indicating strong customer loyalty and service value [5] - The Buy Now, Pay Later Fuse product grew 88% quarter-over-quarter, showing strong merchant adoption [12] - Gross profit grew 37% year-over-year, driven primarily by sustained TPV growth [7] Market Data and Key Metrics Changes - The company processed payments in 44 markets across the Global South, nearly doubling its footprint over the last five years [9] - Brazil, Mexico, South Africa, and Colombia showed particularly strong TPV growth, with on-demand delivery and e-commerce being key verticals [18] - Alternative payment methods (APMs) accounted for a significant portion of quarterly TPV, reflecting the growing trend in emerging markets [11] Company Strategy and Development Direction - The company aims to capture the massive opportunity in emerging markets, with a total addressable market for digital payments estimated at over $2 trillion [13] - The strategy includes expanding into new geographic markets and enhancing product offerings, such as stablecoin solutions and AI-driven payment methods [10][29] - The company plans to maintain a disciplined capital allocation strategy, focusing on growth investments, liquidity, and shareholder returns [30][31] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in continued strong growth, projecting TPV growth of 50%-60% year-over-year for 2026 [24] - The company acknowledged the inherent volatility in emerging markets but emphasized its ability to navigate these complexities [26] - Management highlighted the importance of scaling operations and maintaining efficiency to drive profitability [15] Other Important Information - The company has returned 64% of adjusted free cash flow generated since 2022 to shareholders and confirmed a dividend policy of 30% of the prior year's free cash flow [31] - The company is introducing operating profit metrics for greater transparency in performance comparisons with industry peers [21] Q&A Session Summary Question: Where will TPV growth come from in 2026? - Management indicated that growth will be broad-based, with strong contributions expected from Latin America, Africa, and new markets in Asia and the Middle East [38] Question: What is the outlook for gross margin in Argentina? - Management noted that Argentina remains a high-growth market despite FX volatility affecting costs, and they expect gross margins to recover as conditions normalize [41][42] Question: What is the status of stablecoin adoption? - Management reported that while there is growing interest in stablecoins, significant volume at checkout has not yet materialized, with more activity seen in digital asset marketplaces [48] Question: What drove the strong gross profit growth in Brazil? - Management attributed the growth to a rebound in TPV and strong monetization from mid-tier merchants, but cautioned that such dispersion may not be sustainable [57] Question: What are the risks to the company's guidance? - Management highlighted global macroeconomic factors, geopolitical risks, and FX volatility as potential risks, while also noting strong partnerships with leading digital companies as a positive factor [89]

Financial Data and Key Metrics Changes - Total Payment Volume (TPV) reached $41 billion, up 60% year-over-year, with a significant acceleration as the year progressed [4][5] - Revenue surpassed $1 billion for the first time, with adjusted free cash flow of $191 million, up 110% year-over-year [7][19] - Net income reached $197 million, reflecting a 63% increase year-over-year, and adjusted EBITDA as a percentage of gross profit expanded by 5 percentage points [7][21] Business Line Data and Key Metrics Changes - TPV retention reached 158% and net revenue retention was 145%, indicating strong customer loyalty and service value [5] - The Buy Now, Pay Later Fuse product grew 88% quarter-over-quarter, showing solid merchant adoption [12] - Gross profit grew 37% year-over-year, driven by sustained TPV growth with merchants [7][19] Market Data and Key Metrics Changes - The company processed payments in 44 markets across the Global South, nearly doubling its footprint over the last five years [9] - Brazil, Mexico, South Africa, and Colombia showed particularly strong TPV growth, with on-demand delivery and e-commerce sectors performing well [18][20] - Argentina's gross profit was impacted by FX volatility and election-related costs, despite strong underlying volume growth [20][41] Company Strategy and Development Direction - The company aims to capture the massive opportunity in emerging markets, with a total addressable market for digital payments estimated at over $2 trillion [13] - The strategy includes expanding into new geographic markets and enhancing product offerings, such as stablecoin solutions and card-present transactions [12][30] - The focus remains on maintaining high growth rates while ensuring operational efficiency and cash generation [15][30] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in navigating the complexities of emerging markets, emphasizing the importance of local financial infrastructure [10][26] - The company expects TPV growth in the range of 50%-60% year-over-year for 2026, with gross profit growth projected at 22.5%-27.5% [24][25] - Management highlighted the potential for new merchant contributions and product innovations to drive future growth [28][29] Other Important Information - The company plans to maintain a disciplined capital allocation strategy, including a dividend policy and a new share repurchase program [31][32] - The return on equity reached 35%, up 10 percentage points year-over-year, reflecting improved profitability and capital return policies [22] Q&A Session Summary Question: TPV growth guidance and sources - Management indicated that TPV growth will come from continued strength in Latin America, consolidation in Africa, and expansion into the Middle East and Asia [38][39] Question: Gross margin in Argentina - Management noted that FX volatility impacted gross margins but remains optimistic about Argentina's long-term growth potential [41][42] Question: Stablecoin and Buy Now, Pay Later contributions - Management expects stablecoin products to confirm product market fit in 2026, with significant contributions likely in 2027 or 2028 [43][44] Question: Brazil's revenue and gross profit growth - Brazil's strong performance was attributed to a favorable product mix and increased monetization, but such growth levels may not be sustainable [57][58] Question: Card-present operations - Management clarified that card-present transactions are part of their innovation pipeline, with no significant upfront OpEx expected in 2026 [64][69] Question: Operational efficiencies and guidance risks - Management acknowledged that operational efficiencies will be more visible in the second half of 2026 due to annualization of late 2025 hirings, with macroeconomic factors posing risks to guidance [87][88]

Financial Data and Key Metrics Changes - Revenue for Q4 2025 was $10,000, down from $24,000 in Q4 2024, reflecting modest revenue fluctuations typical in early commercial stages [20] - Total revenue for 2025 was $81,000, slightly up from $77,000 in 2024, indicating a gradual revenue expansion [21] - Operating expenses for Q4 2025 were $9 million, down from $9.4 million in the prior year, showcasing disciplined expense management [20] - Net loss for Q4 2025 was $7.9 million compared to a net loss of $8.6 million in Q4 2024, demonstrating improved financial control [21] Business Line Data and Key Metrics Changes - Research and development expenses for 2025 were $13.2 million, down from $14.7 million in 2024, driven by lower clinical study costs following the completion of the PRIME study [21] - Selling, general, and administrative expenses were $23.3 million compared to $21.9 million in the previous year, reflecting targeted commercial readiness investments [21] Market Data and Key Metrics Changes - The company engaged with 13 states for partner programs, exceeding its initial goal of six states, and aims to expand to 15-17 states by year-end 2026 [9] - In Europe, the company is working towards CE marking approval for its preterm global test, with submissions expected in the coming months [10] Company Strategy and Development Direction - The company aims to build evidence, access, and commercial infrastructure to drive preterm birth adoption at scale, with a focus on Medicaid and high preterm birth burden states [5][8] - A disciplined approach to market access and commercial infrastructure investments is being maintained, with a focus on expanding partner programs and generating real-world evidence [11][24] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the momentum gained from the PRIME publication and the growing engagement with payers and state-level stakeholders [45] - The company anticipates gradual adoption of its technology, supported by compelling clinical evidence and increasing payer engagement [45] Other Important Information - The company ended 2025 with $95.8 million in cash equivalents, which is expected to fund operations through significant adoption and commercial milestones until 2028 [22][25] - A new Head of Sales and Strategic Accounts has been appointed to enhance commercial execution and market access [15] Q&A Session Summary Question: Can you expand on converting payer discussions and partner programs using outcomes and economic data? - The company highlighted the importance of clinical outcomes and economic benefits in discussions with partners, particularly for state Medicaid agencies [29] - The reduction in NICU admissions is a significant cost driver that partners are interested in [30] Question: What feedback was received at the SMFM conference regarding PRIME? - Engagement with providers and leadership at SMFM was strong, focusing on making the test more accessible [33] - The publication has improved credibility and engagement across various stakeholders [35] Question: How will the company balance investments in successful U.S. states versus global EU launch capital requirements? - The company plans to reallocate spending from clinical and R&D activities towards commercial activities, including EU opportunities [38] Question: Can you elaborate on the profile of the new partner? - The company is negotiating with large health systems, provider payers, and group practices, aiming to implement the PreTRM test as standard care [40] - The new partner is an employer collaborative with multi-state opportunities [42]

Financial Data and Key Metrics Changes - Adjusted pre-tax earnings reached BRL 241 million for Q4 2025, 12.1% above guidance, and BRL 592 million for the full year, 11.5% above guidance [4] - Adjusted net income was BRL 180 million for Q4, 31.5% above guidance, and BRL 502 million for the full year, 14.1% above guidance [5] - Net revenues grew to BRL 3 billion in Q4, up 69% year-over-year, and BRL 10.3 billion for the full year, an 85% increase [9] Business Line Data and Key Metrics Changes - Total payment volume reached BRL 157.5 billion in Q4, up 28%, and BRL 550 billion for the full year, a 31% increase [6] - Cash-in grew to BRL 139.4 billion in Q4, up 27%, and BRL 483.4 billion for the year, up 29% [7] - Deposits increased by 44%, reaching BRL 28.7 billion, indicating growing client trust [7] Market Data and Key Metrics Changes - The credit portfolio reached BRL 24.1 billion, up 128% year-over-year, driven by secured and unsecured products [8] - Personal loans origination more than doubled in Q4, reaching BRL 4.4 billion, up 116% [8] - The average revenue per active client (ARPAC) rose to BRL 71 in Q4, up 52% [9] Company Strategy and Development Direction - The company is focusing on expanding its affluent consumer segment with the launch of Epic, targeting high-income clients [12] - A new Global Account was introduced, allowing multi-currency balances and a global debit card [13] - The strategy includes deepening integration with small and medium businesses and enhancing the B2B ecosystem [15][16] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in maintaining strong growth while managing asset quality, particularly with the shift towards secured products [47] - The company anticipates continued revenue growth and margin expansion in 2026, focusing on credit product penetration and customer engagement [41][42] - Management acknowledged the competitive landscape but remains optimistic about sustaining growth despite new entrants [66][70] Other Important Information - The company reported a significant shift in revenue mix, with float fees and commissions now representing 48% of revenues [10] - The efficiency ratio fell below 50% for the first time, reflecting improved operational leverage [28] - The company is actively seeking additional funding sources to support rapid credit portfolio growth [36][37] Q&A Session Summary Question: Asset quality and credit growth sustainability - Management expects to maintain a strong growth pace with improving asset quality, particularly due to the focus on secured products [47] Question: Evolution of third-party card transactions - Revenues from third-party credit cards represent low teens percentage of total net revenues, with a significant shift towards PicPay's own credit capabilities [49] Question: AI efforts and efficiency - The company has integrated AI into customer service, avoiding the need for thousands of customer service representatives, and is leveraging AI for cross-selling [59] Question: Seasonality in first-quarter guidance - Management acknowledged that Q1 is typically weaker but expects strong performance, with credit card TPV and loan origination remaining robust [64][65] Question: Competition in the private payroll product market - While competition is increasing, management believes they can maintain growth due to strong product offerings and customer relationships [66][70]